Literature DB >> 24119781

Complete recovery from psychosis upon miglustat treatment in a juvenile Niemann-Pick C patient.

Katalin Szakszon1, István Szegedi2, Agnes Magyar2, Eva Oláh2, Mónika Andrejkovics3, Petra Balla3, András Lengyel4, Ervin Berényi5, István Balogh6.   

Abstract

Niemann-Pick disease type C is a rare lipid trafficking disorder characterized by the accumulation of cholesterol and glycosphingolipids in the brain and viscera. Perinatal, early infantile, late infantile, juvenile and adult forms are distinguished based on the age of manifestation. In the juvenile form, patients in their early years are usually, but not always, symptom free, but present with neurodegeneration later in their lives. These include clumsiness, ataxia, seizures, motor and intellectual decline. Psychiatric manifestations may occur at any stage of the disease. These manifestations include schizophrenia, presenile dementia, depression or psychosis. In 2009, miglustat was approved for the therapy of the disease. We present a case of a patient with juvenile Niemann-Pick C disease whose psychosis was reversed completely by miglustat treatment. Based on our clinical experience we suggest considering Niemann-Pick C in cases of therapy-resistant psychosis and encourage the introduction of miglustat in Niemann-Pick C patients even in the most advanced cases, with respect to psychiatric illness.
Copyright © 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral atrophy; Miglustat; Niemann–Pick C; Psychosis

Mesh:

Substances:

Year:  2013        PMID: 24119781     DOI: 10.1016/j.ejpn.2013.08.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

Review 1.  Psychiatric and Cognitive Symptoms Associated with Niemann-Pick Type C Disease: Neurobiology and Management.

Authors:  Thomas Rego; Sarah Farrand; Anita M Y Goh; Dhamidhu Eratne; Wendy Kelso; Simone Mangelsdorf; Dennis Velakoulis; Mark Walterfang
Journal:  CNS Drugs       Date:  2019-02       Impact factor: 5.749

Review 2.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07

3.  Phenotypic variability of Niemann-Pick disease type C including a case with clinically pure schizophrenia: a case report.

Authors:  Tomoya Kawazoe; Toshiyuki Yamamoto; Aya Narita; Kousaku Ohno; Kaori Adachi; Eiji Nanba; Atsuko Noguchi; Tsutomu Takahashi; Masamitsu Maekawa; Yoshikatsu Eto; Masafumi Ogawa; Miho Murata; Yuji Takahashi
Journal:  BMC Neurol       Date:  2018-08-17       Impact factor: 2.474

Review 4.  Miglustat in Niemann-Pick disease type C patients: a review.

Authors:  Mercè Pineda; Mark Walterfang; Marc C Patterson
Journal:  Orphanet J Rare Dis       Date:  2018-08-15       Impact factor: 4.123

5.  Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Npc1-Null Cells.

Authors:  Sanzana Hoque; Yuki Kondo; Nodoka Sakata; Yusei Yamada; Madoka Fukaura; Taishi Higashi; Keiichi Motoyama; Hidetoshi Arima; Katsumi Higaki; Akio Hayashi; Takaki Komiya; Yoichi Ishitsuka; Tetsumi Irie
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

6.  Psychosis in an adolescent girl: a common manifestation in Niemann-Pick Type C disease.

Authors:  Sara Wouters; Linda De Meirleir; Edward Campforts; Annik Lampo
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2014-07-11       Impact factor: 3.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.